Member Info for Howzaty

And it is probable that the collaberation will progress with affimer reagents being utilised for a multitude of targets. Boom ...

As I recollect engagement with Condor commenced in May. I posted that a more appropriate name would have been tortoise but to be fair tortoises can move at a fair pace, Condor not.

Was just discussed on the news that Germany is aiming for herd immunity through vacination by Autumn 2021. Gives an idea of the scale of the problem.

Not an expert but just checked out the market size for Separation and Purification products which employs antibodies currently. Seems its around $14B. Ultimately this is only going one way for Avacta and for the avoidance of doubt thats up. Pleased withthe current Finncap target share price of 310p. Seems like next year is going to be bright and the AVA6000 RNS yet to come this year all things being equal.

AVA6000 submission expected before year end which demands an RNS. However, a statement on this cannot be made in isolation so, something must be said in respect of LFT and BAMS. Also, I would have thought that a statement is likely in respect of the Covid varient. So for me an RNS is nailed on.

I think Al may have learned a lesson with the last RNS, to wit unless youre able to give very positive news and perhaps sight of contracts say nowt. So happy to wait rather than lose 15% on half a story.

Turkeys cant spit.

Same story, that it could jump the species barrier mutate and wipe out humanity. Thats why thousands of birds are being killed by men in white suits and masks.

Just dont see how on earth we can have a chance of winning the current tender since passing the Futility Test would surely have been subject of an RNS. The timing is unfortunate but the current uk tender is far from being the only opportunity out there. The important thing is that we get a good quality product, hopefully best in class, with a ce mark available for sale very quickly.

But say vaccine is 70% effective so 30% will have no protection and will rely on herd immunity. Cant recollect the percentage for that but many many more millions.

Target is 1 million vaccinations a week. Each adult requires two injections. Scope for considerable chaos I would say. Injecting 52 million adults twice with presumably plenty of missed appointments.

In reality little has changed beyond missing a percentage, not all, of predicted LFD sales. In fact the profitability of the base business has improved beyond expectation with expansion of the diagnostics business. More patience required I think.